Evaluation of Serologic Cross-Reactivity Between Dengue Virus and SARS-CoV-2 in Patients with Acute Febrile Illness - United States and Puerto Rico, April 2020-March 2021
This report describes the effect of COVID-19 on serological assays associated with dengue or Zika Virus.
Source: CDC Morbidity and Mortality Weekly Report - Category: American Health Tags: Dengue Fever (DF) MMWR Morbidity & Mortality Weekly Report SARS (Severe acute respiratory syndrome) Source Type: news
More News: American Health | COVID-19 | Dengue Fever | Respiratory Medicine | SARS | USA Health | Zika Virus